Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status

Efficacy of first-line oxaliplatin-based chemotherapy regimens depending on the KRAS mutation status

Objective: to determine the efficacy of 2 oxaliplatin-based chemotherapy regimens (FOLFOX and XELOX) for metastatic colorectal cancer (CRC) depending on the KRAS mutation status and primary tumor location. Materials and methods. We performed retrospective analysis of the data on patients with metast...

Full description

Bibliographic Details
Main Authors: M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, I. A. Pokataev, A. A. Tryakin, A. A. Bulanov, O. V. Sekhina, D. A. Chekini, E. O. Ignatova, S. S. Gordeev, M. D. Budurova, Z. Mamedli, D. V. Podluzhnyy, N. A. Kozlov, S. A. Tyulyandin
Format: Article
Language:Russian
Published: “ABV-press” Publishing house”, LLC 2018-05-01
Series:Тазовая хирургия и онкология
Subjects:
colon cancer
kras gene mutations
chemotherapy
oxaliplatin
Online Access:https://ok.abvpress.ru/jour/article/view/241

Internet

https://ok.abvpress.ru/jour/article/view/241

Similar Items